SR-29065 | m-entrepreneurship.com

Product Name :
SR-29065

Search keywords :
NR1D1

drugId :
null

Target Vo:
Nuclear receptor subfamily 1 group D member 1

Target Vo Short Name :
NR1D1

Moa_Name:
Nuclear receptor subfamily 1 group D member 1 agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology

Active Company_Name :
ChemPartner Corp

Active Indication_Name:
Autoimmune Diseases

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SIRT1 Rabbit mAb Protocol
Fibronectin Rabbit mAb Technical Information
CD68 Antibody (YA529): CD68 Antibody (YA529) is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to CD68. It can be used for WB assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts